Home/Filings/4/0001179110-15-013083
4//SEC Filing

Neos Therapeutics, Inc. 4

Accession 0001179110-15-013083

CIK 0001467652operating

Filed

Sep 2, 8:00 PM ET

Accepted

Sep 3, 9:33 PM ET

Size

5.3 KB

Accession

0001179110-15-013083

Insider Transaction Report

Form 4
Period: 2015-09-01
McDonnell Thomas P
Chief Commercial Officer
Transactions
  • Award

    Stock Option (Right to Buy)

    2015-09-01+43,58643,586 total
    Exercise: $25.50Exp: 2025-09-01Common Stock (43,586 underlying)
Footnotes (1)
  • [F1]This stock option vests in equal yearly installments over a four-year period which began on September 1, 2015.

Issuer

Neos Therapeutics, Inc.

CIK 0001467652

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0001467652

Filing Metadata

Form type
4
Filed
Sep 2, 8:00 PM ET
Accepted
Sep 3, 9:33 PM ET
Size
5.3 KB